GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

PKBK · Jun 30, 2025

PARKE BANCORP, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001437749-25-025079Bank
Sequential deposit growth55thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

1.61% · CORE · VALID

Net-income growth75thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

28.32% · CORE · VALID

Interest-income growth80thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

16.02% · CORE · VALID

Cash and equivalents40thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$184.3M · CORE · VALID

Sequential loan growth65thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

2.75% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History61 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Decreased
Previous
2.18%
Current
1.61%
Delta
-0.58%
Earnings Growth Increased
Previous
26.45%
Current
28.32%
Delta
1.87%
Interest Income Growth Increased
Previous
14.82%
Current
16.02%
Delta
1.19%
Liquidity Decreased
Previous
$209.0M
Current
$184.3M
Delta
-$24.8M
Loan Growth Increased
Previous
0.79%
Current
2.75%
Delta
1.96%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.